Drug Trial Radar · NCT05215132
Investigational MRI Clinical Software and Hardware
Last checked: Nov 19, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
2,000
Planned (sponsor's estimate)
Start
Dec 19, 2019
Primary completion
Jan 31, 2028
Study completion Jan 31, 2028
Sponsor
- Lead sponsor
- Northwestern UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Patients and healthy volunteers will be scanned in order to test new sequences.
Conditions
- Image, Body
Interventions
MRIRadiation
1.5T or 3T MRI scanner (Siemens Medical Systems)
Gadavist 2Ml Solution for InjectionDrug
Arm 1 and Arm 3 subjects will undergo this intervention (Gadavist 2Ml solution)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Conduct clinical protocol development and validationTime frame: 5 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Northwestern University- Feinberg School of Medicine
Chicago, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.